Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
Published on: February 23, 2024
An In Vitro Comparative Study of Multisource Derived Human Mesenchymal Stem Cells for Bone Tissue Engineering
Yunpeng Zhang1,2, Yixiao Xing1,2, Linglu Jia1,2
11 School of Stomatology, Shandong University , Jinan, P.R. China .
Periodontal ligament stem cells (PDLSCs) show promise for bone tissue engineering, offering a viable alternative to bone marrow-derived mesenchymal stem cells (BM-MSCs). Dental and perinatal MSCs exhibit faster proliferation, while PDLSCs demonstrate robust anti-apoptotic capabilities.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Stem Cell Biology
Background:
- Mesenchymal stem cells (MSCs) are crucial for tissue engineering and regenerative medicine.
- Identifying the optimal MSC source for bone regeneration is critical but remains debated.
- Various MSC sources, including dental, somatic, and perinatal tissues, exist with distinct properties.
Purpose of the Study:
- To compare the biological characteristics of MSCs from seven different tissue origins for bone tissue engineering.
- To identify the most suitable MSC source for enhanced bone regeneration applications.
- To evaluate proliferation, differentiation potential, and signaling pathways of various MSCs.
Main Methods:
- Cultured and analyzed MSCs from dental pulp (DPSCs), periodontal ligament (PDLSCs), gingiva (GMSCs), dental follicle (DFSCs), bone marrow (BM-MSCs), adipose (ADSCs), and umbilical cord (UCMSCs).
- Assessed immunophenotype, multilineage differentiation potential, proliferation rates, and anti-apoptotic capacity under stress.
- Investigated osteogenic differentiation and activation of key signaling pathways (PI3K/AKT, MAPK/ERK, p38 MAPK).
Main Results:
- All MSCs displayed similar immunophenotypes and multilineage differentiation potential.
- Dental and perinatal MSCs showed faster proliferation than somatic MSCs.
- DPSCs and PDLSCs exhibited superior anti-apoptotic ability; BM-MSCs and ADSCs demonstrated the strongest osteogenic potential, followed closely by PDLSCs and DFSCs.
- GMSCs and UCMSCs were most persistent in osteoblast differentiation; distinct signaling pathway activations were observed post-osteogenic induction.
Conclusions:
- Periodontal ligament stem cells (PDLSCs) represent a promising alternative to bone marrow-derived mesenchymal stem cells (BM-MSCs) for bone tissue engineering.
- The choice of MSC source significantly impacts proliferation, survival, and osteogenic differentiation efficiency.
- Understanding MSC behavior and signaling pathways is key to optimizing cell-based bone regeneration strategies.
Related Concept Videos
Mesenchymal Stem Cells
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
Tissue Renewal without Stem Cells
However, failure of such a system...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Adult Stem Cells

